Gilead pens $1.5B buyout option deal for Pionyr Sanofi's en route to more internal innovation, but M&A will tide it over: exec Bayer-backed Century buys Empirica to create brain cancer CAR-Ts Sponsored: Rise in Targeted Therapies Drives Need for Flexible Small-Volume Manufacturing Sarepta taps Codiak's exosome tech in $72.5M neuromuscular disease deal Sanofi spends $425M to double down on Translate Bio mRNA pact, eyes Q4 COVID-19 vax start Giving highly funded but secretive Moderna a run for its money, Juno-lite Sana raises $700M Schrödinger, Google Cloud to supply massively parallel computing efforts to global COVID-19 initiative Featured Story | Tuesday, June 23, 2020 As it continues with its small to medium-sized biotech deals, Gilead has put down $275 million for a 49.9% share in immuno-oncology biotech Pionyr with the option to buy it out completely should it pass muster in early clinical tests. read more |
| |
|---|
|
Top Stories Tuesday, June 23, 2020 Paul Hudson wasted no time when he took the reins at Sanofi, unveiling plans to ditch the company's weakest R&D units and double down on cancer, rare diseases and other “growth drivers” within his first 100 days. Six months on, head of development Dietmar Berger reflects on the R&D shakeup. read more Tuesday, June 23, 2020 Century Therapeutics has bought Empirica to drive development of allogeneic cell therapies against the brain cancer glioblastoma. The induced pluripotent stem cell (IPSC) player, which landed a $215 million investment from Bayer last year, acquired Empirica on the strength of work to create a CAR-T treatment for glioblastoma. read more Monday, June 22, 2020 Innovative therapies target small numbers of patients. Smaller demand for a therapy, means that sterile injectable manufacturing needs to accommodate smaller batch sizes and more flexibility. read more Tuesday, June 23, 2020 Sarepta is on the hunt for new ways to deliver genetic medicines. Its latest target? A system the body’s cells use to communicate with each other. The company is teaming up with Codiak Biosciences to develop engineered exosomes that can deliver gene therapy, gene editing or RNA-based treatments. read more Tuesday, June 23, 2020 Sanofi Pasteur is betting big on its pact with mRNA biotech Translate Bio as it deepens its ties and commitment to infectious disease vaccines using this new tech. read more Tuesday, June 23, 2020 Sana Biotechnology has got some major backing after coming out with a huge $700 million initial funding round and the ex-financial and research team from Juno Therapeutics. read more Tuesday, June 23, 2020 Digital molecule designer Schrödinger is expanding its efforts against the novel coronavirus, using its partnership with Google’s cloud computing division to screen new potential antivirals as part of a global Big Pharma collaboration. read more Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
| |
|---|
|
Resources Presented by: Cytiva On-demand video: fuel gene therapy development and production with modern AAV workflows. Sponsored by: Automation Anywhere Built on advances in Artificial Intelligence (AI), data mining, and information integration into various systems at 100% accuracy, the new era of intelligent automation is integral to life sciences for devising new treatments faster and at a lower expense. Sponsored by: Cenduit Download this case study to read how Cenduit helped one client successfully navigate mid-study changes to medication management. Sponsored by: Research Solutions Learn four ways to squeeze more value from your limited R&D resources. Sponsored by: BioAnalytix Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Sponsored by: Catalent In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Presented by: ICON Clinical Research Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now. | COVID19 provisions – training will be on-site as normal. | New – may be possible for some individuals to access the training virtually in real time. | 